AstraZeneca PLC header image

AstraZeneca PLC

AZN

Equity

ISIN GB0009895292 / Valor 982352

LSE London Stock Exchange, SETS (2026-06-04)
GBP 135.54+2.60%

AstraZeneca PLC
UMushroom community rating:

star star star star star
4.05 20 votes No rating yet
NegativeNeutralPositive

About company

AstraZeneca PLC is a global pharmaceutical company with a focus on the discovery, development, and commercialization of prescription medicines across various therapy areas. The company is science-led and patient-focused, aiming to address unmet medical needs by bringing innovative medicines to market. AstraZeneca operates in key therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology, with a growing pipeline in rare diseases. Its business strategy emphasizes growth through innovation, leveraging advanced therapeutic modalities and engaging in strategic partnerships to enhance healthcare outcomes. AstraZeneca's commitment to healthcare extends to improving access to its medicines globally, ensuring it plays a significant role in transforming the future of healthcare.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

25.9%1Y
15.4%3Y
68.2%5Y

Performance

24.1%1Y
24.0%3Y
23.7%5Y

Volatility

Market cap

281757 M

Market cap (USD)

Daily traded volume (Shares)

910,310

Daily traded volume (Shares)

1 day high/low

104.82 / 103.6

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.05

20 votes
Performance:
starstarstarstarstar
3.66
Innovation:
starstarstarstarstar
4.24
Society:
starstarstarstarstar
3.74
Nature:
starstarstarstarstar
3.39
Aran Grant
United Kingdom, 09 Nov 2025
star star star star star
Health stocks nice and stable
Deny Purwanto
United Kingdom, 09 Nov 2025
star star star star star
.
Korbinian Kramer
United Kingdom, 08 Nov 2025
star star star star star
Strong growth due to the comapnies strength in innovation and high drug demand

EQUITIES OF THE SAME SECTOR

Metropolis Healthcare Ltd.
Metropolis Healthcare Ltd. Metropolis Healthcare Ltd. Valor: 11536062
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.45%INR 543.55
Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.17%CHF 324.60
Option Care Health Inc
Option Care Health Inc Option Care Health Inc Valor: 52359365
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%USD 20.07
Galenica Ltd.
Galenica Ltd. Galenica Ltd. Valor: 36067446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.09%CHF 83.30
Idorsia Ltd
Idorsia Ltd Idorsia Ltd Valor: 36346343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
9.77%CHF 4.45
Alkermes PLC
Alkermes PLC Alkermes PLC Valor: 13920929
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.45%USD 43.38
Medacta Group Ltd
Medacta Group Ltd Medacta Group Ltd Valor: 46852522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.47%CHF 137.80
Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.44%USD 20.14
SHL Telemedicine Ltd
SHL Telemedicine Ltd SHL Telemedicine Ltd Valor: 1128957
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CHF 1.00
Evolva Holding LTD
Evolva Holding LTD Evolva Holding LTD Valor: 126205578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-13.51%CHF 1.60